摘要:
The invention relates to application of 4,4′-diphenylmethane-bis(methyl) carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
摘要:
The present invention comprises a humanized monoclonal antibody that binds to the chemokine receptor CCR4. This antibody is derived from Mab 1567 and recognizes the same epitope. Binding of the invented antibody to CCR4 inhibits ligand-mediated activities and is used to treat symptoms of cancer. Moreover, the antibody is used in combination with vaccines to suppress the activity of regulatory T cells.
摘要:
A mobile packet gateway obtains a network address of the terminal and a network address of a gateway virtual interface. The network address of the gateway virtual interface and the network address of the terminal belong to a same network segment. A virtual interface is created for a Packet Data Protocol Context (PDP context) of the MS according to the network address of the gateway virtual interface. A network segment address of a branch network served by the MS is obtained from the MS through the virtual interface according to a dynamic routing protocol.
摘要:
A mobile packet gateway obtains a network address of the terminal and a network address of a gateway virtual interface. The network address of the gateway virtual interface and the network address of the terminal belong to a same network segment. A virtual interface is created for a Packet Data Protocol Context (PDP context) of the MS according to the network address of the gateway virtual interface. A network segment address of a branch network served by the MS is obtained from the MS through the virtual interface according to a dynamic routing protocol.
摘要:
The invention relates to application of 4,4′-diphenylmethane-bis(methyl) carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
摘要:
There is disclosed a gene-delivery compound comprising: (A) a single-chain binding polypeptide having at least one effector segment which includes at least one cysteinyl residue; and (B) a nucleic acid-binding moiety which is coupled to the polypeptide via the cysteinyl residue. There is disclosed also a gene-delivery compound comprising: (A) a single-chain, binding polypeptide having at least one effector segment which includes at least one cysteinyl residue; (B) a lipid-associating moiety which is coupled to the polypeptide via the cysteinyl residue. Additionally disclosed are compositions comprising the above-mentioned compounds and a nucleic acid.
摘要:
A method, migration manager, and system of storage system migration. The method includes creating a first zone including a host system in a first SAN-based storage system and an in-band SAN virtualization storage node. The method creates a second zone including a backend storage system in the first SAN-based storage system and the in-band SAN virtualization storage node. A storage unit exported by the backend storage system is mapped to a virtual storage unit created on the in-band SAN virtualization storage node, and a third zone including the host system and backend storage system in the first SAN-based storage system is canceled. The method is performed without disrupting an existing connection path between the host system and the backend storage system in the first SAN-based storage system. A migration manager of a migration system migrates a first SAN-based storage system into an in-band SAN virtualization storage system.
摘要:
The present invention comprises a humanized monoclonal antibody that binds to the chemokine receptor CCR4. This antibody is derived from Mab 1567 and recognizes the same epitope. Binding of the invented antibody to CCR4 inhibits ligand-mediated activities and is used to treat symptoms of cancer. Moreover, the antibody is used in combination with vaccines to suppress the activity of regulatory T cells.
摘要:
The present invention relates to a pharmaceutical composition for preventing and treating diabetic complications, mainly referring to diabetic nephropathy, and the pharmaceutical composition comprises one or both of calycosin and calycosin-7-O-β-D-glucoside as 0.1˜99.5% by weight based on the total weight of the composition, and the conventional drug carrier. The pharmaceutical composition could significantly prevent and treat diabetic nephropathy, with the convenience of quality control and administration, which provides a new drug candidate for patients with diabetic nephropathy.
摘要:
The invention relates to a pharmaceutical composition for diabetic nephropathy and its preparation, and the application in preparing of medicine for diabetic nephropathy. The pharmaceutical composition is made up of at least one of 7-hydroxycoumarin and 7-hydroxy-6-methoxycoumarin as active ingredient, and the weight percentage of active ingredient is 0.1-99.5%. Moreover, the pharmaceutical composition is mainly used for the prevention and cure of diabetic nephropathy. For the abundant material, remarkable effect on prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.